Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07) - Concepedia

Concepedia

Publication | Open Access

Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)

DOI Full Paper Access

63

Citations

72

References

2020

Year

Sara A. Hurvitz, Jennifer L. Caswell‐Jin, Katherine McNamara, Jason J. Zoeller, Gregory R. Bean, Robert Dichmann, Alejandra Perez, Ravindranath Patel, Lee M. Zehngebot, Heather Allen,

Nature Communications

References

	Year	Citations

Page 1